We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$130M
Cap. Flow
-$1.78M
Cap. Flow %
-0.12%
Top 10 Hldgs %
37.99%
Holding
1,491
New
177
Increased
331
Reduced
310
Closed
190

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$17.5M
2
ZION icon
Zions Bancorporation
ZION
+$7.39M
3
VO icon
Vanguard Mid-Cap ETF
VO
+$5.2M
4
AAPL icon
Apple
AAPL
+$2.95M
5
BAC icon
Bank of America
BAC
+$2.74M

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Financials 7.49%
3 Healthcare 6.83%
4 Consumer Discretionary 6.07%
5 Industrials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWR icon
26
iShares Russell Mid-Cap ETF
IWR
$56.5B
$11.5M 0.78%
138,057
-2,680
-2% -$220K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.06T
$11.3M 0.77%
37,762
+4,322
+13% +$1.24M
JNJ icon
28
Johnson & Johnson
JNJ
$624B
$11.2M 0.76%
65,601
+2,807
+4% +$460K
CSCO icon
29
Cisco
CSCO
$444B
$10.1M 0.69%
159,488
+2,429
+2% +$139K
COST icon
30
Costco
COST
$411B
$9.36M 0.64%
16,491
+1,201
+8% +$615K
LECO icon
31
Lincoln Electric
LECO
$13.7B
$9.3M 0.63%
66,720
-898
-1% -$125K
EFA icon
32
iShares MSCI EAFE ETF
EFA
$76.1B
$8.78M 0.6%
111,633
+1,981
+2% +$157K
DIS icon
33
Walt Disney
DIS
$161B
$8.46M 0.58%
54,629
+2,255
+4% +$364K
VNQ icon
34
Vanguard Real Estate ETF
VNQ
$39.1B
$8.42M 0.57%
72,590
-1,712
-2% -$187K
PFE icon
35
Pfizer
PFE
$143B
$8.3M 0.56%
140,518
+9,487
+7% +$470K
ABBV icon
36
AbbVie
ABBV
$454B
$8.15M 0.55%
60,182
+2,451
+4% +$290K
PGR icon
37
Progressive
PGR
$120B
$8.11M 0.55%
78,956
-2,024
-2% -$193K
INTC icon
38
Intel
INTC
$504B
$8.1M 0.55%
157,338
+1,830
+1% +$93.6K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$3.88T
$7.95M 0.54%
54,960
-1,360
-2% -$197K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$7.86M 0.53%
16,553
+17
+0.1% +$7.8K
UNH icon
41
UnitedHealth
UNH
$385B
$7.17M 0.49%
14,285
+661
+5% +$299K
VTI icon
42
Vanguard Total Stock Market ETF
VTI
$654B
$7.17M 0.49%
29,708
+3,161
+12% +$746K
KEY icon
43
KeyCorp
KEY
$24.4B
$6.93M 0.47%
299,673
+3,653
+1% +$84.8K
XOM icon
44
ExxonMobil
XOM
$650B
$6.92M 0.47%
113,019
-1,571
-1% -$98.2K
MRK icon
45
Merck
MRK
$322B
$6.89M 0.47%
89,856
+2,469
+3% +$197K
MCD icon
46
McDonald's
MCD
$187B
$6.68M 0.45%
24,929
+828
+3% +$209K
ARCC icon
47
Ares Capital
ARCC
$13.4B
$6.64M 0.45%
313,500
+20,792
+7% +$432K
NKE icon
48
Nike
NKE
$60.8B
$6.6M 0.45%
39,574
+679
+2% +$112K
IEFA icon
49
iShares Core MSCI EAFE ETF
IEFA
$185B
$6.55M 0.45%
87,806
-9,244
-10% -$695K
V icon
50
Visa
V
$669B
$6.52M 0.44%
30,096
+1,234
+4% +$265K

Similar funds

Clearstead Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Clearstead Advisors held 1,491 positions worth $1.47B, up 9.7% from $1.34B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Clearstead Advisors's Q4 2021 filing shows 177 new, 331 increased, 310 reduced and 190 closed positions. Its largest new stake was WisdomTree Emerging Markets SmallCap Dividend Fund: 20,558 shares worth $1.09M. The largest sale was JPMorgan Chase, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Clearstead Advisors's largest Q4 2021 buy was WisdomTree Emerging Markets SmallCap Dividend Fund: 20,558 shares worth $1.09M.
  • Clearstead Advisors added most to Amcor in Q4 2021, an estimated $3.96M increase.
  • Clearstead Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $17.5M.
  • Clearstead Advisors fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2021, selling an estimated $1.16M.
  • Clearstead Advisors's ten largest holdings make up 38% of its $1.47B portfolio in Q4 2021.
  • Clearstead Advisors opened 177 new positions and closed 190 in Q4 2021.
  • Clearstead Advisors's portfolio value rose 9.7% quarter-over-quarter to $1.47B.

Based on Clearstead Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.